Cite
HARVARD Citation
Keane, C. et al. (n.d.). CD4+ Tumor infiltrating lymphocytes are prognostic and independent of R‐IPI in patients with DLBCL receiving R‐CHOP chemo‐immunotherapy. American journal of hematology. 88 (4), pp. 273-276. [Online].